Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking through the pain: supportive words may ease IUD insertion

NCT ID NCT07326007

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a doctor using a calm, supportive script during IUD insertion could lower pain compared to neutral instructions. It involved 88 women who had only had C-sections and no vaginal births. The goal was to see if simple talk could make the procedure more comfortable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
structured verbal analgesia (supportive communication protocol)
What this could lead to
If it works, this could offer a simple, drug-free way to reduce pain during IUD insertion for women with previous C-sections.
What could go wrong
This is a small, single-center trial with only 88 participants. The effect may be modest or not apply to other groups or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

88 people

The number who actually took part.

Started

Oct 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 18-45 years. * Requesting Copper T380A intrauterine device insertion. * Delivery history limited to cesarean section(s), with no prior vaginal delivery. * Regular menstrual cycles. * Eligible for Copper T380A IUD insertion according to World Health Organization medical eligibility criteria. * Able to provide written informed consent. Exclusion Criteria: * Current pelvic infection, cervicitis, or vaginitis. * Uterine anomalies or fibroids distorting the uterine cavity. * Any contraindication to Copper T380A IUD insertion. * Contraindication to ibuprofen. * Use of analgesic medication within 6-8 hours before insertion. * Pregnancy or suspected pregnancy. * Severe dysmenorrhea requiring narcotic analgesia.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Contraception are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contraception

Contacts and locations

Locations

  • Algezeera Hospital

    Giza, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.